These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7049649)

  • 1. Drug receptors: considerations of their functional properties in disease and pharmacologic intervention.
    Taylor P
    Drug Ther; 1982; ():121-38. PubMed ID: 7049649
    [No Abstract]   [Full Text] [Related]  

  • 2. Diseases caused by antibodies to receptors.
    Flier J
    Clin Immunol Rev; 1981-1982; 1(2):215-56. PubMed ID: 6299639
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoimmune diseases involving nicotinic receptors.
    Lindstrom J
    J Neurobiol; 2002 Dec; 53(4):656-65. PubMed ID: 12436428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of myasthenia gravis by preventing acetylcholine receptor modulation.
    Losen M; Martínez-Martínez P; Phernambucq M; Schuurman J; Parren PW; De Baets MH
    Ann N Y Acad Sci; 2008; 1132():174-9. PubMed ID: 18567867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of myasthenia gravis].
    Téllez Zenteno JF; Morales Buenrostro LE; Torre Delgadillo A
    Rev Invest Clin; 2000; 52(1):80-5. PubMed ID: 10818814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of acetylcholine receptors at neuromuscular junctions: analysis by specific antibodies.
    Stanley EF; Drachman DB
    Ann N Y Acad Sci; 1987; 505():121-32. PubMed ID: 3479925
    [No Abstract]   [Full Text] [Related]  

  • 9. Adult onset acquired myasthenia gravis in three Great Dane littermates.
    Kent M; Glass EN; Acierno M; Shelton GD
    J Small Anim Pract; 2008 Dec; 49(12):647-50. PubMed ID: 18684140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic aspects of disorders of neuromuscular transmission. 1. Myasthenia gravis].
    Andreis I; Lovnicki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):154-8. PubMed ID: 7968204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and antibody-mediated channelopathies at the neuromuscular junction.
    Vincent A; Mills K
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():250-8. PubMed ID: 10689470
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis: an example of receptor disease.
    Conti-Tronconi BM; Fumagalli G; Scotti A; Brigonzi A; Sher E; Morgutti M; Clementi F
    Adv Biochem Psychopharmacol; 1980; 21():473-88. PubMed ID: 7376974
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune diseases against cell surface receptors: myasthenia gravis, a prototype anti-receptor disease.
    De Baets MH
    Neth J Med; 1994 Dec; 45(6):294-301. PubMed ID: 7838246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell receptors in disease.
    Jacobs S; Cuatrecasas P
    N Engl J Med; 1977 Dec; 297(25):1383-6. PubMed ID: 200842
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental rabbit model of myasthenia gravis produced with acetylcholine receptor of nicotinic type from the "generating organ" of electric ray (author's transl)].
    Tu LH
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Feb; 14(1):16-8. PubMed ID: 7307781
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoimmune disorders of neuromuscular transmission.
    Mahadeva B; Phillips LH; Juel VC
    Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.